TAFASITAMAB vs TAGRAXOFUSP-ERZS: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
TAFASITAMAB vs TAGRAXOFUSP-ERZS: Safety Overview
| Metric | TAFASITAMAB | TAGRAXOFUSP-ERZS |
|---|---|---|
| Total FAERS Reports | 1,392 | 438 |
| Deaths Reported | 475 | 114 |
| Death Rate | 34.1% | 26.0% |
| Hospitalizations | 433 | 116 |
| Average Patient Age | 70.0 yrs | 65.9 yrs |
| % Female Patients | 50.1% | 22.8% |
| Manufacturer | Incyte Corporation | N/A |
| Route | INTRAVENOUS | N/A |
| Marketing Status | N/A | Prescription |